ESC Congress 2003: Closing a common heart defect improves migraineAugust 31, 2003IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology We observed that closing a small common heart defect (patent foramen ovale, PFO) for the prevention of stroke, unexpectedly reduced the occurrence of migraine attacks. The small hole was non-surgically closed by placing an umbrella device through a catheter into the heart defect (transcatheter PFO closure). Given that up to half of patients with migraine with aura - that is migraine with perfidious neurological symptoms preceding the headaches - have been found to live with such a small heart defect, this could be a novel treatment for prevention of migraine. Migraine headaches afflict about one tenth of the population at some time. Migraine with aura are migraine headaches, preceded by neurological symptoms similar to stroke warning sings like trouble seeing in one eye, trouble speaking, or numbness or weakness in arm or leg. Up to half of all patients with migraine with aura are reported to have an innocent heart defect (a PFO). To further explore the association between PFO and migraine with aura, we investigated the effect of closing the PFO on migraine headaches. We looked at 215 young adults undergoing transcatheter PFO closure after recovery from stroke. In all patients, the small heart defect was the most likely cause for the stroke. The PFO can serve as shortcut for small blood clots originating form the veins, permitting them to cross into the arterial system and to block a vessel that carries oxygen to the brain. In this situation, for the prevention of an additional stroke the blood must be liquefied with drugs, or the culprit hole must be closed. This can be achieved by transcatheter closure, as we did in our patients. Using a structured questionnaire, we asked our patients to quantify and characterize any kind of headache the year before and after PFO closure. For avoiding any influence on our patients' answers, we did not inform them about a possible relationship between the procedure and migraine headaches. Nearly a quarter of all patients complained about migraine the year prior to PFO closure. This is twice as much as expected in the general European population. One year after PFO closure, 4 out of 5 patients with migraine reported a marked reduction of their migraine attacks. On average, every second migraine attack was abolished after PFO closure. A quarter of all patients with migraine before PFO closure had no further headache during the year after the intervention. This was observed in patients with migraine with and without aura. In contrast, we did not observe a reduction of headache attacks after transcatheter PFO closure in patients with tension-type or other kind of headaches. Currently it is not known by which mechanism transcatheter PFO closure reduces migraine attacks. One theory is, that small blood clots passing the PFO might trigger migraine attacks. The clots are probably too small to obstruct large brain vessels and to cause a stroke, but they may lead to small underperfused areas in the brain, sufficient to trigger a migraine attack. According to another theory, a PFO may allow crossing of highly active biological substances into the arterial circulation. These yet unknown substances originating from the veins are usually cleared in the lungs, but may reach the brain via a PFO, and trigger migraine attacks. Our findings need to be confirmed in well-designed clinical trials. If our observations can be validated, the search for a PFO may become an integral part of the diagnostic work-up of migraine headache. The prospect, that transcatheter PFO closure, a simple cardiac intervention, may reduce migraine attacks or even cure some patients from migraine is encouraging for all those suffering from this disabling condition. PD Dr. Stephan Windecker Swiss Cardiovascular Center Bern, Cardiology University Hospital, 3010 Bern, Switzerland European Society of Cardiology (ESC) |
|||||||||||||||||||||
| Related Stroke Current Events and Stroke News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Fat around the middle increases the risk of dementia Women who store fat on their waist in middle age are more than twice as likely to develop dementia when they get older, reveals a new study from the Sahlgrenska Academy. New discovery about the formation of new brain cells The generation of new nerve cells in the brain is regulated by a peptide known as C3a, which directly affects the stem cells' maturation into nerve cells and is also important for the migration of new nerve cells through the brain tissue, reveals new research from the Sahlgrenska Academy published in the journal Stem Cells. Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." New understanding about mechanism for cell death after stroke leads to possible therapy Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage. Surgery not linked to memory problems in older patients For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions. Pushing the brain to find new pathways Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities. Night Beat, Overtime and a Disrupted Sleep Pattern Can Harm Officers' Health A police officer who works the night shift, typically from 8 p.m. to 4 a.m., already is at a disadvantage when it comes to getting a good "night's" sleep. Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. The benefits of exercise Physical exercise is one of the most effective methods of preventing disease. The current issue of Deutsches Arzteblatt International is devoted to this important topic. More Stroke Current Events and Stroke News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||